Plus: Benefits of reducing antipsychotic medication dose during maintenance treatment of stable patients. Read more inside.
View web version

April 5, 2018

Welcome to the Schizophrenia Advisor Channel e-newsletter from

Schizophrenia Advisor Channel
Potential for SERMs as Adjunctive Therapy for Schizophrenia
Reduced Schizophrenia Maintenance Dose Improves Cognitive Function, Negative Symptoms
Treatment-Resistant Schizophrenia or Medication Underexposure?
Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
Self-Stigmatization Affects Medication Adherence in Schizophrenia
Psychotic Disorders Associated With Early Dynamic Cognitive Impairment
Clinical Advisor
Schizophrenia: Diagnosis and Management

Want to receive emails specific to your profession and specialty? Click here to complete your profile.